TRCT
PETX

Tower Research Capital (TRC)’s Aratana Therapeutics, Inc. PETX Stock Holding History

Tower Research Capital (TRC)’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,679
Closed -$6K – 4695
2019
Q1 		$6K Sell
1,679
-2,157
-56% -$9.35K ﹤0.01% 3022
2018
Q4 		$24K Buy
3,836
+3,076
+405% +$18.8K ﹤0.01% 1811
2018
Q3 		$4K Sell
760
-504
-40% -$2.52K ﹤0.01% 3261
2018
Q2 		$5K Sell
1,264
-10,517
-89% -$53K ﹤0.01% 3100
2018
Q1 		$52K Buy
+11,781
New +$52.6K ﹤0.01% 1659
2017
Q4 		– Sell
-8,524
Closed -$52K – 4329
2017
Q3 		$52K Buy
+8,524
New +$53.9K ﹤0.01% 1940
2017
Q2 		– Sell
-1,971
Closed -$10K – 3845
2017
Q1 		$10K Sell
1,971
-2,627
-57% -$17.7K ﹤0.01% 1809
2016
Q4 		$33K Buy
+4,598
New +$37.2K ﹤0.01% 1723
2016
Q3 		– Sell
-100
Closed -$1K – 4924
2016
Q2 		$1K Sell
100
-1,129
-92% -$7.26K ﹤0.01% 4290
2016
Q1 		$7K Sell
1,229
-92
-7% -$346 ﹤0.01% 2454
2015
Q4 		$7K Buy
+1,321
New +$8.73K ﹤0.01% 2665
2015
Q2 		– Sell
-1,246
Closed -$20K – 5337
2015
Q1 		$20K Buy
+1,246
New +$22.2K ﹤0.01% 2265
2014
Q4 		– Sell
-706
Closed -$7K – 5040
2014
Q3 		$7K Buy
706
+595
+536% +$7.21K ﹤0.01% 3104
2014
Q2 		$2K Sell
111
-2,075
-95% -$29.4K ﹤0.01% 3519
2014
Q1 		$41K Buy
+2,186
New +$43.8K 0.01% 1248
2013
Q3 		– Sell
-10
Closed – – 5005
2013
Q2 		$0 Buy
+10
New +$79 ﹤0.01% 4009

Other funds holding PETX

BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OAC
OMERS Administration Corp Toronto, Ontario, Canada $15.6B AUM 24.73% 1-Year Est. Return

Tower Research Capital (TRC)'s PETX Position: Q2 2019 in Review

Tower Research Capital (TRC) sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2019, closing a stake of 1,679 shares — an estimated $6K sold.

Tower Research Capital (TRC) first reported a position in PETX in Q2 2013 and held it in 16 quarters. The position peaked at $52K in Q1 2018. 103 funds tracked by Wall St. Rank hold PETX as of Q2 2019.

  • Tower Research Capital (TRC) reported no remaining Aratana Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,679 Aratana Therapeutics, Inc. shares in Q2 2019, an estimated $6K.
  • Tower Research Capital (TRC) first reported a position in Aratana Therapeutics, Inc. in Q2 2013 and held it in 16 quarters.
  • Tower Research Capital (TRC)'s Aratana Therapeutics, Inc. position peaked at $52K in Q1 2018.
  • 103 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2019.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2019, filed 13 Aug 2019.